✦ LIBER ✦

Fournier's Gangrene as a Possible Side Effect of Bevacizumab Therapy for Resected Colorectal Cancer

✍ Scribed by Eric O. Gamboa; Esther H. Rehmus; Nairmeen Haller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Refractory generalized seizures as a pos

✍ Veli Berk, Sevda Ismailogullari, Halil Donmez, Halit Karaca, Mevlude Inanc, Meti 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 193 KB

Bevacizumab Targeted Therapy: Validation

✍ Edward Chu 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 40 KB

Phase II study of FOLFOX, bevacizumab an

✍ Meyerhardt, J.; Stuart, K.; Fuchs, C.; Zhu, A.; Earle, C.; Bhargava, P.; Blaszko 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 84 KB

Identification of serum angiopoietin-2 a

✍ Goede, V; Coutelle, O; Neuneier, J; Reinacher-Schick, A; Schnell, R; Koslowsky, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 484 KB

Aerodigestive Fistula Formation as a Rar

✍ Blevins, Dean P.; Dadu, Ramona; Hu, Mimi; Baik, Christina; Balachandran, Diwakar 📂 Article 📅 2014 🏛 Mary Ann Liebert 🌐 English ⚖ 208 KB

Discontinuation of bevacizumab and FOLFI

✍ Gerardo Rosati, Stefano Cordio, Giuseppe Aprile, Alfredo Butera, Antonio Avallon 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 179 KB